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Strengths and limitations of this study
 ► This is the first study to describe the cost-effective-
ness of the complete care pathway for out-of-hospi-
tal cardiac arrest in England.
 ► This study uses a combination of primary and sec-
ondary data, therefore optimising the use of current-
ly available evidence.
 ► The decision analysis model includes a combination 
of probabilistic and two-way sensitivity analyses to 
address the complex question of cost-effectiveness 
of prehospital critical care in a transparent manner.
 ► A limitation of this study is that is based on theoret-
ic modelling only; the uncertainty in the underlying 
data is addressed by the methods and reflected in 
the presentation of results.
AbStrACt
Objectives This research aimed to answer the following 
questions: What are the costs of prehospital advanced 
life support (ALS) and prehospital critical care for out-
of-hospital cardiac arrest (OHCA)? What is the cost-
effectiveness of prehospital ALS? What improvement in 
survival rates from OHCA would prehospital critical care 
need to achieve in order to be cost-effective?
Setting A single National Health Service ambulance 
service and a charity-funded prehospital critical care 
service in England.
Participants The patient population is adult, non-
traumatic OHCA.
Methods We combined data from previously published 
research with data provided by a regional ambulance 
service and air ambulance charity to create a decision 
tree model, coupled with a Markov model, of costs and 
outcomes following OHCA. We compared no treatment 
for OHCA to the current standard of care of prehospital 
ALS, and prehospital ALS to prehospital critical care. To 
reflect the uncertainty in the underlying data, we used 
probabilistic and two-way sensitivity analyses.
results Costs of prehospital ALS and prehospital critical 
care were £347 and £1711 per patient, respectively. 
When costs and outcomes of prehospital, in-hospital 
and postdischarge phase of OHCA care were combined, 
prehospital ALS was estimated to be cost-effective at £11 
407/quality-adjusted life year. In order to be cost-effective 
in addition to ALS, prehospital critical care for OHCA would 
need to achieve a minimally economically important 
difference (MEID) in survival to hospital discharge of 
3%–5%.
Conclusion This is the first economic analysis to address 
the question of cost-effectiveness of prehospital critical 
care following OHCA. While costs of either prehospital 
ALS and/or critical care per patient with OHCA are 
relatively low, significant costs are incurred during hospital 
treatment and after discharge in patients who survive. 
Knowledge of the MEID for prehospital critical care can 
guide future research in this field.
trial registration number ISRCTN18375201
IntrOduCtIOn
Rates of survival following out-of-hospital 
cardiac arrest (OHCA) remain low in the 
UK, with an overall survival rate to hospital 
discharge of 7.9%.1 One area of potential 
improvement is the provision of prehospital 
care by emergency medical services (EMS).2 
The current standard of prehospital care 
in the UK is the provision of advanced life 
support (ALS) by appropriately trained para-
medics.3 In an attempt to improve survival 
rates following OHCA, prehospital critical 
care teams (CCTs) are dispatched to OHCA 
in some regions in the UK, in addition to 
the standard ALS response.4 5 CCTs consist 
of specialist paramedics and/or doctors, 
with extended skills and competences, which 
we previously described in detail.6 They are 
frequently based on air ambulances, with 
funding received variably through chari-
table donations and/or the National Health 
Service (NHS).7
The cost-effectiveness of ALS care provided 
by paramedics or physicians has been studied 
previously.8 9 However, generalisability of this 
evidence to current UK practice is limited 
due to the elapsed time since the research 
was undertaken and considerable differences 
in EMS configurations. The cost-effectiveness 
of prehospital critical care for OHCA has 
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Figure 1 Final analytic model of prehospital critical care following out-of-hospital cardiac arrest, combining decision tree 
and Markov model. Due to limited space, the full pathway is shown for the ALS option only. ALS, advanced life support; CPC, 
Cerebral Performance Category; ICU, intensive care unit.
not been researched in sufficient detail to guide funding 
decisions. A recently published systematic review of the 
effectiveness of CCTs for OHCA showed a potential small-
to-moderate survival benefit but also identified issues 
limiting internal and external validities of the included 
observational studies.10
Economic analyses have been undertaken in regard 
to the cost-effectiveness of helicopter-based emergency 
medical services care (HEMS) for trauma, with mixed 
results.11 12 To our knowledge, no economic analysis 
exists that addresses the question of cost-effectiveness of 
prehospital critical care for OHCA. In addition, a recent 
study of stakeholders’ views of prehospital care for OHCA 
revealed contrasting opinion of whether current NHS 
funding of prehospital ALS care for OHCA represents an 
appropriate distribution of limited healthcare resources 
in the UK.13 Adding to the complexity of cost-effective-
ness of prehospital ALS or critical care for OHCA is the 
fact that the majority of costs occur along the patient care 
pathway in hospital or postdischarge.14 15
In the absence of robust data regarding the effective-
ness of prehospital ALS or critical care for OHCA in the 
UK setting, this study addresses the following questions:
 ► What are the costs of prehospital ALS and prehospital 
care for OHCA in the UK?
 ► What is the cost-effectiveness of the current OHCA 
treatment pathway from prehospital ALS care to post-
discharge costs, when compared with no treatment?
 ► What improvement in survival rates from OHCA 
would prehospital critical care need to achieve in 
order to be cost-effective, when compared with ALS?
MethOdS
We combined data from previously published research 
with costs provided by a regional EMS provider and air 
ambulance charity to create a decision analysis model.
development of the decision analysis model
The initial decision analysis model for this research 
considered three potential outcomes: prehospital death, 
in-hospital death or survival to hospital discharge. After 
a focused review of the literature, it became clear that 
differences in in-hospital treatment costs and survival 
with either poor or favourable neurological outcome 
had considerable impact on the cost-effectiveness esti-
mates.14 15 We therefore expanded the model to include 
these important branches in a combination of deci-
sion tree model for prehospital and hospital costs and 
outcomes, and a Markov model for postdischarge costs 
and outcomes. The structure is similar to the model used 
by Gates et al15 in their economic analysis of mechanical 
chest compression during prehospital care for OHCA. 
Figure 1 shows the final model (for simplicity, only the 
ALS arm of the model is displayed). Based on literature 
referenced in the sections below, important assumptions 
are that
 ► A proportion of patients survive to hospital arrival but 
receive palliative care only, resulting in death in the 
emergency department or shortly afterwards.
 ► Patients who survive to hospital discharge with Cere-
bral Performance Category (CPC) scores of 3–4 have 
a higher rate of survival following the first 5 years 
after hospital discharge, compared with those patients 
surviving with CPC scores of 1–2.
 ► After 5 years postdischarge, annual survival rates for 
patients still alive at this point are the same as those of 
the average population.
Perspective and time horizon
In keeping with the recommendations of the National 
Institute for Health and Care Excellence (NICE), the 
perspective on costs chosen for this economic evaluation 
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was that of the NHS and personal social services.16 The 
perspective on outcomes included all direct health effects 
on patients, namely, length and quality of life (quality-ad-
justed life years (QALYs)) with a corresponding long-
term time horizon.
Clinical setting
The economic analysis was undertaken in the section of 
an NHS ambulance trust in England that was covered by a 
CCT. It covers an area of 2.930 square miles with a popu-
lation of approximately 2.5 million people. The area is 
largely suburban or rural with one metropolitan area and 
two urban areas. The overall population density is 860/
square mile. The patient population is adult, non-trau-
matic OHCA.
Alternative interventions: ALS and prehospital critical care
The NHS ambulance trust provided ALS paramedic care, 
using a combination of first responders, rapid response 
vehicles and ambulance. The section of the ambulance 
trust included in this analysis contained 27 ambulance 
stations with a total of approximately 800 ALS paramedics 
(employed part time or full time), as well as emergency 
care assistants and ambulance technicians (data provided 
by ambulance trust). The median response time for OHCA 
during the study period was 7.4 min (IQR 4.9–11.4 min), 
and care on scene was provided by a mean of 2.43 core 
resources (paramedic-staffed double-crewed ambulances 
and/or rapid response vehicles). The prehospital critical 
care service was funded largely through an air ambulance 
charity but also received support from the ambulance trust. 
It provided prehospital critical care cover from 07:00–13:00, 
with access to a helicopter and rapid response vehicles. The 
team consisted of specialist paramedics in critical care and 
prehospital critical care doctors. The service responded 
to OHCAs in addition to the usual ambulance trust’s ALS 
response.
Identification and synthesis of evidence
Costs
Financial data were obtained from the ambulance 
trust and air ambulance charity for the financial year 
2015/2016. This included pay for clinical and non-clinical 
staff, as well as costs of dispatch infrastructure, ambulance 
stations, vehicles, fuel, medical supplies, communica-
tions equipment, community first responders and third-
party costs. The amount of funding spent on OHCA was 
calculated as the number of OHCA cases divided by the 
number of cases of any aetiology. Calculating the propor-
tion of resources spent on OHCA in this fashion distrib-
utes the costs of waiting time of resources in between 
emergency proportionally between OHCA cases and 
those of other aetiologies.17 The costs of in-hospital and 
postdischarge treatment were synthesised from relevant 
recent publications, identified by a focused systematic 
search of the literature (online supplementary appendix 
1).14 15 18
Outcomes
After a literature review (online supplementary appendix 
2), the following outcomes of interest were included 
in the decision analysis model (figure 1): survival to 
arrival at hospital; survival to intensive care unit (ICU) 
admission, survival to hospital discharge, CPC score at 
discharge from hospital, 5-year survival following hospital 
discharge, annual mortality and quality of life. Prehos-
pital outcomes after OHCA with ALS care were based on 
a 1-year data sample provided by the participating ambu-
lance trust (2016), while in-hospital outcomes were based 
on recent literature of OHCA in the UK.19–21 For prehos-
pital critical care, a range of effect sizes were simulated in 
two-way sensitivity analyses.10 This approach was chosen 
to transparently reflect the considerable uncertainty of 
the effectiveness of prehospital critical care for OHCA in 
current research.10 Postdischarge outcomes for the first 5 
years after hospital discharge were retrieved from publi-
cations identified through a further focused systematic 
search of the literature (online supplementary appendix 
2).15 22 Further long-term outcomes (quality of life) were 
modelled according to survival rates provided by the UK’s 
Office for National Statistics.23 24
Application of values and distributions to the model
Prior to inclusion in the model, all costs were adjusted to 
pound sterling for the financial year 2016–2017 according 
to the UK Hospital and Community Health Services pay 
and prices index.25 In keeping with NICE guidelines, 
an annual discount rate of 3.5% was applied to costs 
and effects that occurred after the first year following 
discharge from hospital.16 Table 1 provides a comprehen-
sive list of all model parameters based on the sources of 
data described in the previous section. The CIs or IQRs 
of the data were transferred to sampling distributions.26 
In keeping with previous recommendations, we used 
gamma distributions for costs and beta distributions for 
probabilities.26 Each parameter in table 1 corresponds to 
either a cost, effect or probability of each chance node or 
Markov node of the decision analysis model in figure 1. 
For costs and effects, these are simply added up for each 
potential outcome. For example, in-hospital death after 
prehospital critical care would incur the costs of prehos-
pital critical care plus ALS, costs of ED treatment, and 
ICU and non-ICU costs of non-survivors. The effect is 0f 
QALYs, as the outcome is death. The probabilities for 
each node were entered into the model as the values 
described in table 1, with the exception of the probability 
of survival to hospital discharge. To create a 10% rate of 
survival to hospital discharge after prehospital critical 
care, for example, the probability value for the corre-
sponding node would need to be entered as a function of 
‘10%, divided by p ICU admission, divided by p survival 
to hospital’.
Sensitivity analyses
As the analysis was based largely on secondary data, 
we undertook a probabilistic sensitivity analysis of the 
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Table 2 Prehospital treatment costs for OHCA
ALS care Critical care
Total expenditure 2015–2016 (in £)
  Staff costs 36 732 844 665 293
  Vehicles (including fuel) 8 145 245 13 659
  Helicopter (including fuel) – 1 318 432
  Buildings 2 705 442 37 693
  Equipment 1 681 383 63 296
  Other 6 261 901 37 752
  Dispatch centre 2 226 955 45 000
  Total 57 753 770 2 181 125
Expenditure per OHCA 2015–2016 (in £)
  Percentage (%) of 
resources devoted to 
OHCA
0.85 30.0
  Number of patients with 
OHCA
1412 388
  Cost per patient with 
OHCA
347 1711
ALS, advanced life support; OHCA, out-of-hospital cardiac arrest.
decision analysis model to reflect the underlying uncer-
tainty in the data.26 We ran 1000 iterations of the deci-
sion analysis model in a Monte Carlo simulation. For each 
iteration, the values of all model parameters were drawn 
at random from the sampling distributions described 
in table 1. In addition, the probabilities of survival to 
hospital admission and survival to hospital discharge after 
prehospital critical care were subject to a two-way sensi-
tivity analysis, reflecting a range of potential effects based 
on a recent systematic review.10 All analysis was under-
taken in TreeAge V.2017.
Model validation
Validity of decision analysis models can be examined in 
a number of different ways.26 Face validity was examined 
by presenting the model, values and results to a group 
of prehospital clinicians and air ambulance charity staff. 
Internal validity was assessed through the sensitivity anal-
yses described previously, as well as selecting extreme 
values for each individual parameter in the model and 
checking if the results were influenced as expected. We 
also undertook visual inspection of the values selected 
by the software for each variable during the probabi-
listic sensitivity to ensure that values were in the ranges 
expected for the parameter. While the software produced 
an error message if probabilities either did not add up to 
one or had individual values of less than 0 or more than 
1, we also hand checked all probabilities to assure that the 
overall probability of death/survival was correctly calcu-
lated from the probabilities at each step of the decision 
tree model.
Presentation of results
In keeping with the three research questions outlined in 
the introduction, the results will be presented in three 
sections. First, we will describe the costs occurring during 
prehospital care for OHCA, for both ALS and critical 
care. Outcome measure will be pound sterling. We will 
then describe the cost-effectiveness of prehospital ALS, 
including the complete patient pathway, when compared 
with no treatment. The outcome measure will be the incre-
mental cost-effectiveness in pound sterling per QALY. 
Finally, we will analyse the MEID that prehospital critical 
care would need to achieve in order to be cost effective at 
a willingness-to-pay (WTP) threshold of £20 000/QALY. 
The outcome measure will be the absolute difference in 
survival to hospital discharge between ALS and prehos-
pital critical care, which fulfils the MEID criteria.
Patient and public involvement
A patient and public involvement (PPI) group was 
consulted during the application and planning process 
of the doctoral research fellowship, which underlies this 
research. In addition, the PPI groups’ views, as well as other 
relevant stakeholders’ views, expressed during previous 
research13 informed the methods of this research. Results 
will be disseminated to all stakeholders who participated, 
through an executive summary of this research.
reSuLtS
Prehospital costs
Table 2 gives an overview of the costs of prehospital ALS 
care and prehospital critical care for OHCA. The total 
expenditure for ALS care is over 25 times higher than the 
costs of providing prehospital critical care for the same 
geographical area. However, OHCAs represent approxi-
mately one-third of the workload of the prehospital CCT, 
whereas only 0.85% of ALS care funding can be attributed 
to OHCA care. The average cost of a patient with OHCA 
being attended by ALS paramedics is £347, while the cost 
for attendance of a prehospital CCT is £1711 (plus £347, 
as ALS resources would still be dispatched with CCT 
attendance).
Cost-effectiveness of ALS for OhCA
The estimated cost-effectiveness of the current standard 
pathway for OHCA, including prehospital ALS, hospital 
admission, ICU and non-ICU treatment, as well as post-
discharge healthcare costs, is £11 407/QALY (median, 
IQR £6840/QALY–£16 863/QALY), when compared with 
no treatment. Figure 2 shows the corresponding scatter 
plot with results from 1000 iterations of the probabilistic 
sensitivity analysis. As the majority of these 1000 results 
lie below the WTP threshold of £20 000/QALY (approxi-
mately 93%), prehospital ALS for OHCA can be assumed 
to be cost-effective at this WTP threshold with a high 
degree of certainty.
Incremental cost-effectiveness of prehospital critical care for 
OhCA
Figure 3 shows the cost-effectiveness acceptability curves 
for a number of potential treatment effects of prehospital 
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Figure 2 Scatter plot of the cost-effectiveness of advanced 
life support for out-of-hospital cardiac arrest, compared with 
no treatment. QALY, quality-adjusted life year.
Figure 3 Cost-effectiveness acceptability curves of different 
plausible treatment effects of prehospital critical care for 
out-of-hospital cardiac arrest, when compared with ALS. The 
underlying baseline survival to hospital discharge for the ALS 
cohort in this model is 9.0%. ALS, advanced life support; 
QALY, quality-adjusted life year.
critical care following OHCA. For this model, the ratio 
of rates of survival to arrival at hospital and survival to 
hospital discharge in the prehospital critical care treat-
ment arm was kept constant. Rates of survival to hospital 
arrival and of survival to hospital discharge after ALS 
care for OHCA were 25.8% and 9.0%, respectively. The 
intersections of the WTP threshold and the cost–accept-
ability curves provide the probability of prehospital crit-
ical care being cost-effective. Prehospital critical care 
needs to achieve a 2% or 3% absolute increase in survival 
to hospital discharge to have a 48% or 72% probability 
of being cost effective at a WTP threshold of £20 000/
QALY, respectively. With a lower absolute difference in 
survival rates of 1%, prehospital critical care has a less 
than 1% probability of being cost effective at the same 
WTP threshold. Higher absolute differences in survival 
of 4%, 5% and 6% result in probabilities of cost-effective-
ness at the WTP threshold of £20 000 of 84%, 90% and 
93%, respectively.
The results of the analysis presented in figure 3 assume 
that the rates of survival to hospital increase propor-
tionally with the rates of survival to hospital discharge. 
However, as the majority of costs for the care of OHCA is 
generated by in-hospital treatments, variations in the rate 
of survival to hospital can have considerable influence on 
costs, independent of later survival to hospital discharge. 
Table 3 provides estimates and IQRs for possible combi-
nations of survival to hospital and survival to hospital 
discharge rates. As table 3 demonstrates, higher rates of 
survival to hospital arrival result in moderate increases in 
incremental costs of prehospital critical care for OHCA.
Table 4 presents a further sensitivity analysis of the 
effects of varying costs of prehospital critical care and 
rates of survival to hospital discharge. Variations in the 
costs of prehospital critical care for OHCA only have a 
minor-to-moderate effect on its cost-effectiveness.
dISCuSSIOn
In this decision model analysis, the cost-effectiveness 
of prehospital ALS care or prehospital critical care for 
OHCA was determined to a considerable degree by 
their effects on short-term and long-term survival, with 
the majority of costs incurred during hospital treatment 
or postdischarge.
Prehospital costs versus later costs
Given the complexity of the economic analysis of 
the whole OHCA pathway, it is worth first looking at 
prehospital resource use only. The ambulance service 
described in this analysis had an annual spending of 
over £50 million. However, during the study period, 
patients with OHCA represented only 0.22% of all 
emergency calls attended. Even with the requirement 
for more resources per patient with OHCA compared 
with most other prehospital conditions, only 0.82% 
of the annual spending was allocated to OHCAs at an 
estimated cost of £347 per OHCA. This might seem a 
rather low amount of money to be spent on the imme-
diate care for a life or death situation.13
In contrast, the annual costs of providing a helicop-
ter-based prehospital CCT covering the same geograph-
ical area was relatively low, at just over 2 million pounds 
per year. Due to the fact that the CCT attended to much 
fewer patients (approximately 1200 during the study 
period) with a higher proportion of OHCAs (30%), the 
incremental costs of prehospital critical care per OHCA 
were estimated at £1711. Given the gravity of the acute 
situation of an OHCA, this incremental cost might be 
considered an effective use of EMS resources.
Focusing only on prehospital costs of OHCA would 
make comparison to other healthcare interventions 
difficult and would ignore the importance of costs accu-
mulating further along the OHCA pathway. For patients 
with OHCA, where resuscitation is unsuccessful and 
who are declared dead on scene, no further costs occur. 
However, a large proportion (25.8% in this cohort) of 
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Table 3 Incremental cost-effectiveness of prehospital critical care for out-of-hospital cardiac arrest (in pound sterling per 
quality-adjusted life year) for different rates of survival to hospital and survival to hospital discharge, compared with advanced 
life support
Difference in 
rates of survival 
to hospital
Difference in rates of survival to hospital discharge (median, 95% CI)
+1% +2% +3% +4% +5% +6%
−5% 25 000 (16 500 
to 46 000)
18 000 (12 500 
to 28 500)
15 500
(11 000 to 
23 500)
14 500 (10 500 
to 21 000)
Not achievable Not achievable
0% 27 500 (20 000 
to 47 500)
19 000 (14 500 
to 30 000)
16 500 (12 500 
to 24 500)
15 000 (11 500 
to 22 000)
14 000 (11 000 to 
20 000)
13 500 (10 500 to 
19 000)
+5% 30 500 (21 500 
to 53 000)
20 500 (15 500 
to 33 500)
17 000 (13 000 
to 26 500)
15 500 (12 000 
to 23 000)
14 500 (11 500 to 
21 500)
14 000 (11 000 to 
20 000)
+10% 33 500 (22 500 
to 61 000)
22 000 (16 000 
to 37 500)
18 000 (14 000 
to 28 500)
16 500 (12 500 
to 24 500)
15 000 (12 000 to 
22 000)
14 500 (11 500 to 
21 000)
+15% 36 500 (23 000 
to 70 500)
23 500 (17 000 
to 42 000)
20 000 (14 500 
to 32 000)
17 000 (13 000 
to 26 500)
16 000 (12 500 to 
23 500)
15 000 (11 500 to 
22 000)
+20% 39 500 (23 500 
to 79 500)
24 500 (17 000 
to 46 000)
20 000 (15 000 
to 34 000)
17 500 (13 500 
to 29 000)
16 500 (12 500 to 
25 500)
15 500 (12 000 to 
23 000)
Light and darker shades of grey indicate most likely combination of differences in rates of survival to hospital and survival to hospital 
discharge. All costs are in pound sterling and have been rounded to the nearest £500 value.
Table 4 Incremental cost-effectiveness of prehospital critical care for out-of-hospital cardiac arrest (in pound sterling per 
quality-adjusted life year) for a range of costs of prehospital critical care and different rates of survival to hospital discharge, 
compared with advanced life support
Difference 
in costs of 
prehospital care
Difference in rates of survival to hospital discharge (median, 95% CI)
+1% +2% +3% +4% +5% +6%
−50% 20 000 (16 000 
to 33 500)
16 000 (13 000 
to 25 500)
15 000 (12 000 
to 23 000)
14 000 (11 500 
to 21 500)
14 000 (11 000 
to 21 000)
13 500 (11 000 
to 20 500)
−20% 25 000 (19 000 
to 43,000)
18 500 (14 500 
to 30 500)
16 500 (13 000 
to 26 000)
15 500 (12 500 
to 24 000)
15 000 (12 000 
to 23 000)
14 500 (11 500 
to 22 000)
0% 28 000 (21 500 
to 50 500)
20 000 (16 000 
to 33 500)
17 500 (14 000 
to 28 500)
16 000 (13 000 
to 25 500)
15 500 (12 500 
to 24 000)
15 000 (12 000 
to 23 000)
+20% 31 500 (24 000 
to 57 500)
22 000 (17 000 
to 37 000)
18 500 (14 500 
to 30 500)
17 000 (13 500 
to 27 000)
16 000 (13 000 
to 25 500)
15 500 (12 500 
to 24 000)
+50% 36 000 (27 500 
to 67 500)
24,00 (18 500 to 
41 500)
20 000 (16 000 
to 33 500)
18 000 (14 500 
to 30 000)
17 000 (13 500 
to 27 000)
16 000 (13 000 
to 25 500)
All costs are in pound sterling and have been rounded to the nearest £500 value.
Boldfaced values represent the baseline analysis; light grey shaded areas represent likely national variations in costs.
patients with OHCA survive the prehospital phase of 
their care and are admitted to a hospital. We estimated 
the costs of in-hospital treatment to be approximately 
£22 000 for patients surviving to hospital discharge 
and £8500 for patients who die in the hospital.14 20 The 
major contributors to these costs are ICU-bed days (all 
patients) and interventions such as primary percu-
taneous coronary intervention (PPCI), implantable 
cardioverter defibrillator (ICD) implantation or coro-
nary artery bypass graft surgery (almost exclusively in 
survivors).14 Further costs can accumulate after hospital 
discharge, most importantly the long-term care services 
required for the small proportion of patients who 
survive to hospital discharge with poor neurological 
function (over £40 000/year).15
Cost-effectiveness of ALS for OhCA
We estimated the cost-effectiveness of paramedic-de-
livered ALS for OHCA to be approximately £11 500/
QALY. With the upper limit of the IQR at approximately 
£16 800, this makes ALS for OHCA almost certainly 
cost-effective at a NICE WTP threshold of £20 000/
QALY.16
While a number of previous publications address the 
cost-effectiveness of individual aspects of prehospital care 
or hospital care for OHCA,27–29 only a few address the 
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cost-effectiveness of ALS for OHCA in the context of the 
complete patient pathway. Næss and Steen30 estimated 
the cost-effectiveness of ALS for OHCA in Norway to be 
approximately £6000/QALY in 2004. This much lower esti-
mate is likely due to inflation since the year of publication 
but also development of in-hospital cardiac arrest care with 
higher rates of interventions in modern OHCA care and 
the costs associated with this.20 31 More recently, Ginsberg et 
al32 reported the cost-effectiveness of ALS for OHCA to be 
$28 864 per disability-adjusted life year averted in an Israeli 
EMS, corresponding to approximately £15 000/QALY–£28 
500/QALY.33 Despite some uncertainty of the data under-
lying this analysis and taking previous research findings into 
account, we can be fairly certain that paramedic-delivered 
ALS is a cost-effective treatment for OHCA in the UK. In 
addition, in terms of pound sterling per QALY, it compares 
favourably with a range of interventions currently funded 
by the NHS.34 35
Costs of prehospital critical care
As the current observational research describing the effec-
tiveness of prehospital critical care for OHCA is inconsis-
tent and likely suffers from confounding,10 we decided not 
to include it in this probabilistic sensitivity analysis. Instead, 
we used a range of potential absolute effect sizes on rates 
of survival to hospital discharge, ranging from 1% to 6%, 
reflecting the most likely range of effect sizes.10 This sensi-
tivity analysis also allowed us to determine a minimally 
economically important difference (MEID) in survival 
rates, which would need to be achieved by prehospital crit-
ical care services in order to be cost-effective.
At a WTP threshold of £20 000/QALY, the MEID is in 
the range of 3%–5% absolute improvement in survival 
to hospital discharge after OHCA. Any improvement 
in survival rates after OHCA of less than 3%, caused by 
prehospital critical care services, is very unlikely to be 
considered cost-effective within an NHS setting.16 The 
exact value for the MEID depends on how certain stake-
holders want to be about the cost-effectiveness estimate 
at a given WTP (figure 3), the rates of survival to hospital 
admission (table 3) and the exact costs of a given prehos-
pital critical care service (table 4). The MEID can be used 
to guide sample size calculations of future research and to 
frame the expectations or aims of stakeholders and prehos-
pital critical care services providing care for OHCA.13 Inter-
estingly, the MEID of prehospital critical care for OHCA 
calculated in this analysis equals the minimally clinically 
important difference in survival following OHCA described 
in previous research.36
Limitations
This economic analysis is based on a theoretical construct 
of the costs and effects of the care pathway for OHCA. As 
such, assumptions about events occurring in reality had 
to be made and had to be assumed to reflect reality accu-
rately, in order for the model to be internally valid.26 On 
the other hand, using a modelling approach allowed us to 
incorporate a considerable number of data sources and to 
undertake a range of sensitivity analyses, which improved 
generalisability. While we undertook steps to ensure the 
face validity and the internal validity of the model, we were 
unable to reliably test the external validity (through simula-
tion of real life events).
We did not adapt a microcosting approach that would 
have, for example, included the exact number of para-
medics at the scene for an OHCA or the amount of drugs 
or equipment used. Such an approach would have likely 
resulted in an overall more accurate estimate of the costs 
of ALS care for OHCA, but would have required tremen-
dous efforts to collect and analyse the data. As costs occur-
ring in the later stages of care for OHCA were much higher 
than those during the prehospital phase, a microcosting 
approach would have been unlikely to change the cost esti-
mate for prehospital care significantly. Reassuringly, the 
estimated cost of £347 for ALS care for OHCA compares 
realistically to the NHS National Schedule of Reference 
Costs of an average of £236 for ‘see and treat and convey’ 
ambulance activities (considering the higher resource use 
for patients with OHCA).37
The main driver of costs for prehospital critical care was 
the helicopter, followed by staffing costs. We are aware of 
a number of prehospital critical care services that attend 
OHCAs using only ground vehicles. This would certainly 
reduce overall costs of the service (and is therefore reflected 
in the sensitivity analysis) but also the number of OHCAs 
that the CCT could reach, particularly in rural/suburban 
areas. In regard to the validity of the overall model, there 
are few previous publications to compare to. Reassuringly, 
Delgado et al38 used a similar decision model analysis 
approach to examine the potential cost-effectiveness of 
HEMS for trauma cases in the USA. They found that a 3.7% 
absolute decrease in mortality was required for HEMS to be 
cost-effective at a WTP of $50 000 (£38 000)/QALY.
This analysis focuses exclusively on adult, non-traumatic 
OHCA, as OHCA due to trauma or occurring in the paedi-
atric population is much rarer and due to distinctively 
different pathology. Results should not be extrapolated to 
these situations.
COnCLuSIOn
This is the first economic analysis, based on a decision 
analysis model, to address the question of cost-effective-
ness of prehospital critical care following OHCA. While 
costs of either prehospital ALS or critical care per patient 
with OHCA are relatively low, significant costs are incurred 
during hospital treatment and after discharge in patients 
who survive. Taking the whole OHCA care pathway into 
account, prehospital ALS, as currently delivered in most 
NHS ambulance trusts, is very likely to be cost-effective at 
a WTP of £20 000/QALY. For prehospital critical care to 
be cost-effective at the same WTP threshold, it would need 
to improve survival from OHCA by approximately 3%–5%.
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